<SEC-DOCUMENT>0000899243-20-003818-index.html : 20200210
<SEC-HEADER>0000899243-20-003818.hdr.sgml : 20200210
<ACCEPTANCE-DATETIME>20200210162028
ACCESSION NUMBER:		0000899243-20-003818
CONFORMED SUBMISSION TYPE:	5
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200210
DATE AS OF CHANGE:		20200210

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Watson W. Mark
		CENTRAL INDEX KEY:			0001612372

	FILING VALUES:
		FORM TYPE:		5
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13467
		FILM NUMBER:		20592216

	MAIL ADDRESS:	
		STREET 1:		324 S. HYDE PARK AVENUE
		STREET 2:		STE 350
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33606

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inhibitor Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001042418
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				541641133
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4830 W. KENNEDY BLVD.
		STREET 2:		SUITE 600
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609
		BUSINESS PHONE:		(813) 766-2462

	MAIL ADDRESS:	
		STREET 1:		4830 W. KENNEDY BLVD.
		STREET 2:		SUITE 600
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HedgePath Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20130816

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMMONWEALTH BIOTECHNOLOGIES INC
		DATE OF NAME CHANGE:	19970714
</SEC-HEADER>
<DOCUMENT>
<TYPE>5
<SEQUENCE>1
<FILENAME>doc5.xml
<DESCRIPTION>FORM 5 SUBMISSION
<TEXT>
Document 1 - file: doc5.html

Document 1 - RAW XML: doc5.xml

</DOCUMENT>
</SEC-DOCUMENT>